Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Viking Therapeutics, Inc.”

8 pharma patents match "Viking Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "Viking Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “Viking Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12421282

    Compositions and methods for the treatment of metabolic and liver disorders

    Viking Therapeutics, Inc. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12318426

    Compositions and methods for the treatment of metabolic and liver disorders

    Viking Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  3. US 12102646

    Compositions for the treatment of fibrosis and inflammation

    Viking Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  4. US 11951114

    Use of thyroid beta-agonists

    Viking Therapeutics, Inc. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  5. US 11744873

    Compositions and methods for the treatment of metabolic and liver disorders

    Viking Therapeutics, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  6. US 11707472

    Compositions for the treatment of fibrosis

    Viking Therapeutics, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  7. US 11351183

    Use of thyroid beta-agonists

    Viking Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  8. US 11202789

    Method of treating glycogen storage disease

    Viking Therapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted